MIT researchers develop analytics focused on accelerating COVID-19 therapeutics clinical trials and attracting more funding for vaccines and anti-infectives. Disclaimer: AAAS and EurekAlert! are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results